Pharma Focus Europe

QIAGEN and Element Biosciences Announce Partnership to Deliver Comprehensive Next-Generation Sequencing Workflows for the AVITI System

Friday, November 03, 2023

QIAGEN and Element Biosciences have entered into a strategic partnership to provide comprehensive next-generation sequencing (NGS) workflows for the AVITI™ System, a state-of-the-art sequencing platform built on Element's innovative Avidity sequencing chemistry.

The AVITI System, known for its versatile benchtop sequencer offering exceptional performance and cost-effectiveness, is designed to generate high-quality, affordable data for a wide range of applications and scales. QIAGEN, in collaboration with Element Biosciences, is offering Sample to Insight NGS workflows for AVITI System users. These workflows include validated QIAseq panels and integrated bioinformatic solutions, featuring CLC LightSpeed and QCI Interpret software.

QIAGEN, emphasized the significance of this collaboration, stating, "The collaboration between QIAGEN and Element Biosciences delivers unparalleled insights across various genomic applications to our customers worldwide. Researchers are increasingly seeking complete solutions and workflows from sample to insight, and we are committed to advancing the field together by providing innovative technology and applications that help researchers accelerate discovery."

Element Biosciences, also expressed their commitment to providing flexible, cost-effective, and high-performance solutions. He said, "Element and QIAGEN share the goals of offering flexible, cost-effective, and high-performance solutions to our customers. Jointly promoting the combined workflow will help us serve an expanded customer base with the backing of a global genomic powerhouse like QIAGEN."

QIAGEN's QIAseq panels play a crucial role in enabling efficient and accurate NGS library preparation. Several QIAseq panels, including the QIAseq miRNA Library Kit, the QIAseq xHYB Actionable Exome Panel, and the QIAseq Targeted DNA Pro Panel, have been rigorously validated on the AVITI sequencer, demonstrating robust performance, high specificity, and coverage uniformity, as well as consistent variant detection.

LightSpeed, a new module integrated into QIAGEN CLC Genomics Workbench Premium, empowers AVITI System users to conduct cost-effective secondary analysis for whole genome sequencing (WGS) with exceptional speed. QCI Interpret, a fully customizable software solution, simplifies NGS variant interpretation and reporting for oncology and hereditary applications, having already issued over 3 million reports.

QIAGEN Digital Insights, highlighted the potential of NGS in advancing precision medicine and acknowledged a key challenge in the efficient downstream analysis and interpretation of processed samples. He stated, "There is a huge potential for NGS to deliver on the vision of precision medicine. One of the greatest barriers to ubiquitous adoption and use is the efficient downstream analysis and interpretation of processed samples. We are pleased to partner with Element Biosciences to deliver joint solutions that enable customers to rapidly adopt, automate, and scale their NGS needs with higher cost efficiencies and faster turnaround times."

 

Source: prnewswire.com

magazine-slider-img
Thermo Fisher Scientific - mRNA ServicesWorld Orphan Drug Congress 2024World Vaccine Congress Europe 2024Advanced Therapies USA 2024
cytiva